OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unconventional T Cell Targets for Cancer Immunotherapy
Dale I. Godfrey, Jérôme Le Nours, Daniel M. Andrews, et al.
Immunity (2018) Vol. 48, Iss. 3, pp. 453-473
Open Access | Times Cited: 272

Showing 1-25 of 272 citing articles:

Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 151-167
Closed Access | Times Cited: 1423

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2019) Vol. 49, Iss. 10, pp. 1457-1973
Open Access | Times Cited: 874

Harnessing innate immunity in cancer therapy
Olivier Demaria, Stéphanie Cornen, Marc Daëron, et al.
Nature (2019) Vol. 574, Iss. 7776, pp. 45-56
Closed Access | Times Cited: 751

The biology and functional importance of MAIT cells
Dale I. Godfrey, Hui‐Fern Koay, James McCluskey, et al.
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1110-1128
Closed Access | Times Cited: 458

Immunotherapy and targeted therapy combinations in metastatic breast cancer
Francisco J. Esteva, Vanessa M. Hubbard-Lucey, Jun Tang, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 3, pp. e175-e186
Closed Access | Times Cited: 405

Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
Marc Rigau, Simone Ostrouska, Thomas S. Fulford, et al.
Science (2020) Vol. 367, Iss. 6478
Closed Access | Times Cited: 346

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 2708-3145
Open Access | Times Cited: 314

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko, Steven A. Rosenberg
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 454-472
Open Access | Times Cited: 312

Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 302

Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 166

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78

Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function
Chiara Rancan, Marcel Arias-Badia, Pranay Dogra, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 612-624
Open Access | Times Cited: 42

Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41

Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 41

MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1
Juming Yan, Stacey Allen, Elizabeth S. McDonald, et al.
Cancer Discovery (2019) Vol. 10, Iss. 1, pp. 124-141
Open Access | Times Cited: 119

T cell antigen discovery
Alok V. Joglekar, Guideng Li
Nature Methods (2020) Vol. 18, Iss. 8, pp. 873-880
Closed Access | Times Cited: 112

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Eva Pérez‐Guijarro, Howard H. Yang, Romina E. Araya, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 781-791
Open Access | Times Cited: 100

A multilayered immune system through the lens of unconventional T cells
Toufic Mayassi, Luis B. Barreiro, Jamie Rossjohn, et al.
Nature (2021) Vol. 595, Iss. 7868, pp. 501-510
Open Access | Times Cited: 94

Peptides as cancer vaccines
Marta Calvo Tardón, Mathilde Allard, Valérie Dutoit, et al.
Current Opinion in Pharmacology (2019) Vol. 47, pp. 20-26
Closed Access | Times Cited: 84

Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells
Christophe Paget, François Trottein
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 78

Early-life imprinting of unconventional T cells and tissue homeostasis
Michael G. Constantinides, Yasmine Belkaid
Science (2021) Vol. 374, Iss. 6573
Open Access | Times Cited: 75

Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
Jan A. Rath, Caroline Arber
Cells (2020) Vol. 9, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 72

Single-cell RNA sequencing identifies shared differentiation paths of mouse thymic innate T cells
Minji Lee, Eunmin Lee, Seong Kyu Han, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 71

TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer
Laura S.M. Lecker, Chiara Berlato, Eleni Maniati, et al.
Cancer Research (2021) Vol. 81, Iss. 22, pp. 5706-5719
Open Access | Times Cited: 67

Page 1 - Next Page

Scroll to top